20Apr
Related Posts
27May
Next Science (ASX:NXS) – breakthrough antimicrobial technologies
27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and the company's recent FDA approval.
Read More
21Aug
Cauldron Energy (ASX:CXU) – portfolio of assets supporting the clean energy transition
21 Aug 2023 - Cauldron Energy Limited (ASX:CXU) CEO Jonathan Fisher discusses the company's progress with its portfolio of assets, including the Melrose nickel-copper project in WA.
Read More
16Dec
Botanix Pharmaceuticals (ASX:BOT) clinical trial update
16 Dec 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Founder Matthew Callahan talks about the company's Phase 2 US trial results for severe acne, plans for its Phase 3 trails, including FDA input, its Phase 2 atopic dermatitis study, and what investors can expect over the next 6 months.
Read More
03Apr
Novonix (ASX:NVX) announces Saudi joint venture
03 Apr 2023 - Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses the company's JV with TAQAT to produce anode materials for electric vehicles.
Read More
16Aug
Elsight (ASX:ELS) – TechKnow Invest Roadshow, August 2023
16 Aug 2023 - Yoav Amitai - CEO - Elsight's (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.
Read More
04Sep
Margin over ounces: Westgold’s strong production results
04 Sep 2023 - Westgold Resources (ASX:WGX) Managing Director Wayne Bramwell provides an update on the company, discussing drivers behind production results, the gold price, and plans going forward.
Read More
17Jun
From Challenger to Revolution
17 June 2025 - How Bob Sahota turned a defensive credit philosophy into one of Australia’s most respected private debt funds.
Read More
07Jul
Knosys (ASX:KNO) – Overview of LIBERO acquisition
07 Jul 2021 - Knosys Limited (ASX:KNO Managing Director John Thompson provides an overview of the recent acquisition of LIBERO, a leading library management software business.
Read More
17May
Approvals and DFS to resume at Elementos’ Oropesa Tin Project
17 May 2024 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses the recommencement of DFS and licensing activities following discussions with the Andalusian government.
Read More
11Dec
Cyclopharm (ASX:CYC) on pathway to US sales
11 Dec 2020 - Cyclopharm Limited (ASX:CYC) CEO & Managing Director James McBrayer talks about USFDA approval for Technegas, the company's USA commercialisation plan, and opportunities beyond its key diagnostic market for pulmonary embolism.
Read More